Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G
Institute for Biomedical Aging Research, Austrian Academy of Sciences, Innsbruck.
Lancet. 1993 Jan 30;341(8840):255-9. doi: 10.1016/0140-6736(93)92613-x.
Arteriosclerotic lesions can be induced in normocholesterolaemic rabbits by immunisation with heat-shock protein (hsp) 65, a stress protein expressed in high concentrations in human atherosclerotic lesions. If an immune reaction to hsp65 also plays a part in human atherogenesis, it should be possible to detect anti-hsp65 antibodies in patients with atherosclerotic lesions. To study the possible relation between immune reaction to hsp65 and atherosclerosis, 867 normal inhabitants of South Tyrol, aged 40-79 years, were selected randomly for determination of serum antibodies against hsp65, simultaneous sonographic assessment of carotid atherosclerotic lesions, and evaluation of established risk factors--ie, blood cholesterol, hypertension, smoking, diabetes mellitus, and obesity. Autoantibodies to nuclear antigens, thyroid antigens, and rheumatoid factors were also measured. Serum anti-hsp65 antibodies were significantly (p < 0.05) increased in subjects aged 60-79 years with carotid atherosclerosis compared with those without lesions, and increased antibody concentration was independent of age, sex, and other established risk factors. On the other hand, the incidence and titres of autoantibodies did not correlate with carotid atherosclerotic lesions. Our data provide the first evidence of a strong correlation between anti-hsp65 antibodies and carotid atherosclerosis, suggesting that hsp65 might be involved in the pathogenesis of atherosclerosis.
通过用热休克蛋白(hsp)65免疫正常胆固醇血症兔子,可诱发动脉硬化病变。hsp65是一种在人类动脉粥样硬化病变中高浓度表达的应激蛋白。如果对hsp65的免疫反应也在人类动脉粥样硬化形成中起作用,那么应该能够在患有动脉粥样硬化病变的患者中检测到抗hsp65抗体。为了研究对hsp65的免疫反应与动脉粥样硬化之间的可能关系,随机选择了867名年龄在40 - 79岁的南蒂罗尔正常居民,测定其血清中抗hsp65抗体,同时对颈动脉粥样硬化病变进行超声评估,并评估已确定的危险因素,即血胆固醇、高血压、吸烟、糖尿病和肥胖。还检测了针对核抗原、甲状腺抗原的自身抗体和类风湿因子。与无病变者相比,患有颈动脉粥样硬化的60 - 79岁受试者血清抗hsp65抗体显著升高(p < 0.05),且抗体浓度升高与年龄、性别和其他已确定的危险因素无关。另一方面,自身抗体的发生率和滴度与颈动脉粥样硬化病变无关。我们的数据首次证明了抗hsp65抗体与颈动脉粥样硬化之间存在强相关性,表明hsp65可能参与动脉粥样硬化的发病机制。